Literature DB >> 33587215

Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model.

ArunKumar GaneshPrasad1, Saisubramanian Nagarajan2, Niranjana Sri Sundaramoorthy3, Subramaniam Thothathri3, Muthumeenakshi Bhaskaran3.   

Abstract

Bacteriophages are a promising alternative for curtailing infections caused by multi drug resistant (MDR) bacteria. The objective of the present study is to evaluate phage populations from water bodies to inhibit planktonic and biofilm mode of growth of drug resistant Klebsiella pneumoniae in vitro and curtail planktonic growth in vivo in a zebrafish model. Phage specific to K. pneumoniae (MTCC 432) was isolated from Ganges River (designated as KpG). One-step growth curve, in vitro time kill curve study and in vivo infection model were performed to evaluate the ability of phage to curtail planktonic growth. Crystal violet assay and colony biofilm assay were performed to determine the action of phages on biofilms. KpG phages had a greater burst size, better bactericidal potential and enhanced inhibitory effect against biofilms formed at liquid air and solid air interfaces. In vitro time kill assay showed a 3 log decline and a 6 log decline in K. pneumoniae colony counts, when phages were administered individually and in combination with streptomycin, respectively. In vivo injection of KpG phages revealed that it did not pose any toxicity to zebrafish as evidenced by liver/brain enzyme profiles and by histopathological analysis. The muscle tissue of zebrafish, infected with K. pneumoniae and treated with KpG phages alone and in combination with streptomycin showed a significant 77.7% and 97.2% decline in CFU/ml, respectively, relative to untreated control. Our study reveals that KpG phages has the potential to curtail plantonic and biofilm mode of growth in higher animal models.

Entities:  

Keywords:  Bacteriophage; Ganges river; Klebsiella spp.; Phage therapy

Year:  2021        PMID: 33587215     DOI: 10.1186/s13568-021-01181-0

Source DB:  PubMed          Journal:  AMB Express        ISSN: 2191-0855            Impact factor:   3.298


  29 in total

1.  Determination of minimum inhibitory concentrations.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

2.  The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage.

Authors:  G J German; R Misra
Journal:  J Mol Biol       Date:  2001-05-11       Impact factor: 5.469

3.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

4.  Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.

Authors:  Taruna Anand; Nitin Virmani; Sudarshan Kumar; Ashok Kumar Mohanty; S Pavulraj; Bidhan Ch Bera; Rajesh K Vaid; Umang Ahlawat; B N Tripathi
Journal:  J Glob Antimicrob Resist       Date:  2019-10-08       Impact factor: 4.035

5.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

6.  Experimental phage therapy against Staphylococcus aureus in mice.

Authors:  Rosanna Capparelli; Marianna Parlato; Giorgia Borriello; Paola Salvatore; Domenico Iannelli
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

7.  Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.

Authors:  Sanjay Chhibber; Sandeep Kaur; Seema Kumari
Journal:  J Med Microbiol       Date:  2008-12       Impact factor: 2.472

8.  Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.

Authors:  Fang Cao; Xitao Wang; Linhui Wang; Zhen Li; Jian Che; Lili Wang; Xiaoyu Li; Zhenhui Cao; Jiancheng Zhang; Liji Jin; Yongping Xu
Journal:  Biomed Res Int       Date:  2015-03-23       Impact factor: 3.411

9.  Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance.

Authors:  Alita R Burmeister; Abigail Fortier; Carli Roush; Adam J Lessing; Rose G Bender; Roxanna Barahman; Raeven Grant; Benjamin K Chan; Paul E Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-18       Impact factor: 11.205

10.  Isolation and Characterization of Two Klebsiella pneumoniae Phages Encoding Divergent Depolymerases.

Authors:  Pilar Domingo-Calap; Beatriz Beamud; Lucas Mora-Quilis; Fernando González-Candelas; Rafael Sanjuán
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

View more
  1 in total

Review 1.  Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials.

Authors:  Lucile Plumet; Nour Ahmad-Mansour; Catherine Dunyach-Remy; Karima Kissa; Albert Sotto; Jean-Philippe Lavigne; Denis Costechareyre; Virginie Molle
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.